Modafinil

Modafinil, or Provigil, is a prescription oral wakefulness medicine. People seek sustained work or study time. Reports range from productive alertness to tiredness, muddled thinking and later insomnia. Awake does not mean well rested.

Modafinil is a prescription wakefulness medicine; people also discuss it for staying alert through work, study or shift schedules.

Armodafinil is a related, distinct medicine. Modafinil contains two mirror-image forms of the molecule; armodafinil, sold as Nuvigil, contains the R form. Reports of a longer armodafinil tail do not establish milligram-for-milligram equivalence. DailyMed armodafinil identity (Official context · Accessed 2026-09-30) · Modafinil experiences: wakefulness, amounts, sleep and mood (Community discussion · Accessed 2026-09-30)

Source context — DailyMed armodafinil identity: Identity context only, no equivalence rule or armodafinil half-life transferred into modafinil. Exact current publication date not resolved; source metadata includes older section revisions.

Source context — Modafinil experiences: wakefulness, amounts, sleep and mood: Self-selected anonymous reports; oral route follows tablet context but not every comment explicitly states swallowing. Products and diagnoses unverified. Dates from search's dated bodies; opened page relative labels varied between fetches. No prevalence or causality. Mechanism/safety assurances, sourcing and untried analogues excluded.

A quiet effect can still change the day. Some contributors describe simply staying awake, without a high or a strong push to begin tasks. Others feel stimulation, tension or little change. The community nickname 'clean stimulant' describes an impression, not a safety category. Modafinil experiences: wakefulness, amounts, sleep and mood (Community discussion · Accessed 2026-09-30) · Daily prescription benefit with contrary sleep and headache experiences (Community discussion · Accessed 2026-09-30)

Longer work blocks and less dozing. A night-shift contributor described getting through a shift without caffeine. A separate occasional user reported sustained task focus but felt low the next day. These are accounts of usable alertness, not proof of better work or learning. Modafinil experiences: wakefulness, amounts, sleep and mood (Community discussion · Accessed 2026-09-30)

More wakefulness may bring little energy. A prescribed 100 mg morning user with a sleep-disorder context stopped falling asleep at work but remained exhausted and unproductive. Another discussion contains people who felt sleepy or unchanged. That limits the 'smart drug' promise even before considering side effects. First week: less dozing but still exhausted (Personal report · Accessed 2026-09-30) · Daily prescription benefit with contrary sleep and headache experiences (Community discussion · Accessed 2026-09-30)

Staying on task can differ from thinking flexibly. ResolveMassive406 felt awake at 100 mg but struggled to understand mathematics; 50 mg did not solve that difficulty. A programmer replying to the same thread described better divergent thinking. Neither account establishes general cognitive improvement or decline. Awake while mathematics felt harder (Community discussion · Accessed 2026-09-30)

Source context — Modafinil experiences: wakefulness, amounts, sleep and mood: Self-selected anonymous reports; oral route follows tablet context but not every comment explicitly states swallowing. Products and diagnoses unverified. Dates from search's dated bodies; opened page relative labels varied between fetches. No prevalence or causality. Mechanism/safety assurances, sourcing and untried analogues excluded.

Source context — Daily prescription benefit with contrary sleep and headache experiences: One favorable OP with contrary commenters; co-use, medical context, expectations and formulations uncontrolled. No denominator or long-term safety conclusion. Oral route implied.

Source context — First week: less dozing but still exhausted: Sleep-disorder population, not healthy rested users. Exact date not resolved from relative '3mo ago' page; older access date is not publication date. Unverified clinical circumstances.

Source context — Awake while mathematics felt harder: Anonymous self-reports, not performance testing. Rat quotations in reply are not human evidence and are not adopted. Oral route implied. Archived visible thread is not necessarily every original comment.

Oral modafinil: 50 mg per use appears in lower-amount reports. June 2026 contributors describe occasional 50 mg use, including one using it two or three times weekly. Focus, headache, anxiety and sleep trouble all appear; a smaller amount is not a reliably symptom-free experience. Modafinil experiences: wakefulness, amounts, sleep and mood (Community discussion · Accessed 2026-09-30)

Oral modafinil: 100 mg or 200 mg in morning accounts. The Bluelight thread contains separate 100 mg workday and 200 mg first-day reports. The retained 100–200 mg morning range describes individual administrations, not a recommended daily amount or escalation plan. First-day wakefulness followed by inability to sleep (Community discussion · Accessed 2026-09-30)

Armodafinil: 150 mg is separate discussion. The preserved account names that amount for oral armodafinil. Its 'half the milligrams, longer' wording is community lore, not a conversion rule between the two medicines.

Source context — Modafinil experiences: wakefulness, amounts, sleep and mood: Self-selected anonymous reports; oral route follows tablet context but not every comment explicitly states swallowing. Products and diagnoses unverified. Dates from search's dated bodies; opened page relative labels varied between fetches. No prevalence or causality. Mechanism/safety assurances, sourcing and untried analogues excluded.

Source context — First-day wakefulness followed by inability to sleep: Prescribed status claimed while OP also names an online vendor. Cannot authenticate product or prescription; tablet/oral context implied, not confirmed. Procurement and advice excluded. Duplicate old mod-day/review-20260922-modafinil are one account/source origin.

One 200 mg morning account: about 30 minutes. AdNo182 reported a 6am administration and a 6:30am noticeable effect, based on only two uses. This is felt onset, not a blood-concentration peak. Modafinil experiences: wakefulness, amounts, sleep and mood (Community discussion · Accessed 2026-09-30)

Another 200 mg account: within an hour. SophieJ's first-day report describes that timing after 6am use. The old 30–60-minute picture fits these examples, but some accounts report little or no effect rather than a discernible on-switch. First-day wakefulness followed by inability to sleep (Community discussion · Accessed 2026-09-30) · Daily prescription benefit with contrary sleep and headache experiences (Community discussion · Accessed 2026-09-30)

Separate reports: roughly 6 hours versus 6am to 9pm. NowRunThatByMeAgain describes around six hours, with an unstated modafinil amount and some residual sleepiness. AdNo182 describes about fifteen hours after 200 mg. These differing experiences do not define one predictable coverage window. Modafinil experiences: wakefulness, amounts, sleep and mood (Community discussion · Accessed 2026-09-30)

An 8–10+ hour workday can have a longer sleep cost. GabeN reported that coverage mainly at 100 mg. Separately, SophieJ's 200 mg day mellowed near 7pm but still prevented sleep later. Useful focus and bedtime interference can end at different times. A year on modafinil: changing sleep, amounts and weekend breaks (Community discussion · Accessed 2026-09-30) · First-day wakefulness followed by inability to sleep (Community discussion · Accessed 2026-09-30)

Twelve hours is a forum assumption; six hours is one user's guess. LongeCity post #89 uses 12 hours in a clearance calculation without a cited measurement. Post #67 guesses six hours from personal response. Neither measures elimination, and they should not be combined into a human half-life range. Older half-life estimates and differing sleep responses (Community discussion · Accessed 2026-09-30)

The older 10–15-hour talk was label-derived. The original attributes this figure to circulated inserts, not community measurements. Felt duration cannot establish when half the drug has left the body.

About 15 hours after repeated doses. This is the label's effective elimination half-life, not felt duration. Oral blood concentrations peak at 2–4 hours; food can delay that peak about one hour. Neither number specifies a productive or sleep-safe window. DailyMed modafinil tablet labeling (Official context · Accessed 2026-09-30)

Source context — Modafinil experiences: wakefulness, amounts, sleep and mood: Self-selected anonymous reports; oral route follows tablet context but not every comment explicitly states swallowing. Products and diagnoses unverified. Dates from search's dated bodies; opened page relative labels varied between fetches. No prevalence or causality. Mechanism/safety assurances, sourcing and untried analogues excluded.

Source context — First-day wakefulness followed by inability to sleep: Prescribed status claimed while OP also names an online vendor. Cannot authenticate product or prescription; tablet/oral context implied, not confirmed. Procurement and advice excluded. Duplicate old mod-day/review-20260922-modafinil are one account/source origin.

Source context — Daily prescription benefit with contrary sleep and headache experiences: One favorable OP with contrary commenters; co-use, medical context, expectations and formulations uncontrolled. No denominator or long-term safety conclusion. Oral route implied.

Source context — A year on modafinil: changing sleep, amounts and weekend breaks: One retrospective OP and follow-up, not independent corroboration. Sleep, amounts, caffeine and stress change together. Medical/product verification absent. No validated break/reset or long-term safety conclusion.

Source context — Older half-life estimates and differing sleep responses: Six-hour figure inferred from feeling, twelve-hour assumption uncited, 24–30h not measured clearance. Old posts and uncertain products; none establishes human elimination or a safe interval. Quoted posts are not independent respondents. Stack advice and extreme sleep-cycle claims excluded.

Source context — DailyMed modafinil tablet labeling: Label revised6/2022; supporting context, not community doses or felt timing. Pregnancy warning includes animal data and uncertain causality of human reports. Approved indications do not establish enhancement in rested healthy users. Single source family; derivative wording counted together.

Daily, workday-only and rare use all appear. No-Arm-4557 describes prescribed 100 mg daily for nine months without a perceived loss of effect. In June's thread, another contributor describes only four or five uses per year. These are different people's habits, not evidence for an ideal cycle. Daily prescription benefit with contrary sleep and headache experiences (Community discussion · Accessed 2026-09-30) · Modafinil experiences: wakefulness, amounts, sleep and mood (Community discussion · Accessed 2026-09-30)

Weekend breaks do not prove a tolerance reset. GabeN used mainly 100 mg five days weekly, skipping weekends and vacations. After one or two months of nearly daily 200 mg, 100 mg felt weaker; later it felt sufficient as sleep improved. The same person's changing sleep and amounts prevent a clean tolerance conclusion. A year on modafinil: changing sleep, amounts and weekend breaks (Community discussion · Accessed 2026-09-30)

Source context — Daily prescription benefit with contrary sleep and headache experiences: One favorable OP with contrary commenters; co-use, medical context, expectations and formulations uncontrolled. No denominator or long-term safety conclusion. Oral route implied.

Source context — Modafinil experiences: wakefulness, amounts, sleep and mood: Self-selected anonymous reports; oral route follows tablet context but not every comment explicitly states swallowing. Products and diagnoses unverified. Dates from search's dated bodies; opened page relative labels varied between fetches. No prevalence or causality. Mechanism/safety assurances, sourcing and untried analogues excluded.

Source context — A year on modafinil: changing sleep, amounts and weekend breaks: One retrospective OP and follow-up, not independent corroboration. Sleep, amounts, caffeine and stress change together. Medical/product verification absent. No validated break/reset or long-term safety conclusion.

Caffeine and theanine: Appear in productivity discussions, without establishing independent contributions or reliable prevention of headache, anxiety or sleep problems. [community]

Caffeine and L-theanine are stack talk, not fixes. The preserved discussion pairs them with modafinil. Newer caffeine accounts conflict: some tolerate coffee, while others blame the combination for anxiety. Water, electrolytes or choline do not reliably prevent headache in the opened reports. Favorable stack stories do not check interactions. Daily prescription benefit with contrary sleep and headache experiences (Community discussion · Accessed 2026-09-30)

Source context — Daily prescription benefit with contrary sleep and headache experiences: One favorable OP with contrary commenters; co-use, medical context, expectations and formulations uncontrolled. No denominator or long-term safety conclusion. Oral route implied.

Headache, anxiety and insomnia can outweigh the workday. Reports include headaches despite water and electrolytes, irritability and next-day low mood. Even morning use can disturb sleep. The old appetite-loss and 'forgot to eat' pattern also remains relevant; these discussions cannot estimate how often each problem occurs. Modafinil experiences: wakefulness, amounts, sleep and mood (Community discussion · Accessed 2026-09-30) · Daily prescription benefit with contrary sleep and headache experiences (Community discussion · Accessed 2026-09-30)

Food, thirst and sleep shape the diary. Older notes describe food as optional and mention water, sleep and blood pressure. Skipped meals and caffeine make a workday report harder to interpret. Feeling alert on less sleep does not show that the lost sleep has been replaced. Daily prescription benefit with contrary sleep and headache experiences (Community discussion · Accessed 2026-09-30)

Serious rash needs prompt medical assessment. Labeling warns about potentially life-threatening skin reactions, including Stevens–Johnson syndrome. A mild-feeling effect cannot predict this risk. DailyMed modafinil tablet labeling (Official context · Accessed 2026-09-30)

Pregnancy and medication interactions matter. Labeling warns of pregnancy risk and reduced hormonal-contraceptive effectiveness during use and for one month afterward. Other medicine interactions require professional review. DailyMed modafinil tablet labeling (Official context · Accessed 2026-09-30)

Prescription, U.S. Schedule IV. Abuse is possible. Sharing a STUDplan can reveal its modafinil entry. Community accounts cannot establish long-term safety. DailyMed modafinil tablet labeling (Official context · Accessed 2026-09-30) · Daily prescription benefit with contrary sleep and headache experiences (Community discussion · Accessed 2026-09-30)

Source context — Modafinil experiences: wakefulness, amounts, sleep and mood: Self-selected anonymous reports; oral route follows tablet context but not every comment explicitly states swallowing. Products and diagnoses unverified. Dates from search's dated bodies; opened page relative labels varied between fetches. No prevalence or causality. Mechanism/safety assurances, sourcing and untried analogues excluded.

Source context — Daily prescription benefit with contrary sleep and headache experiences: One favorable OP with contrary commenters; co-use, medical context, expectations and formulations uncontrolled. No denominator or long-term safety conclusion. Oral route implied.

Source context — DailyMed modafinil tablet labeling: Label revised6/2022; supporting context, not community doses or felt timing. Pregnancy warning includes animal data and uncertain causality of human reports. Approved indications do not establish enhancement in rested healthy users. Single source family; derivative wording counted together.